15 companies i am tracking part 2-
5. #CUPID - a leading manufacturer & supplier of quality Male & Female Condoms was incorporated as a Public Limited Company in 1993 The companies modern facility has a current capacity of over 500 million pieces per year for Male Condoms and 25 million pieces per year of the Female Condoms..It is the only company in the world to obtain Pre-qualification status from WHO/UNFPA for supply of both Male & Female condoms.The company also has an active R&D center in addition to its main production facility. The company works with healthcare professionals, governments and organizations to support them in promoting good sexual health and the importance of consistent condom use to prevent HIV and other STDs.
6. #Coral Lab - Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported.
7. #CADILAHC -technology-driven pharmaceutical company focused on the research areas of biotechnology, formulations and Active Pharmaceutical Ingredients.The company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products.
8. #AUROPHARMA -Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins, APL is running with 29 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities. Aurobindo Pharma has identified international operations also catering to over 150 countries. Cumulatively, the Company has filed a total of 337 DMFs (Drug Master Files), of which 110 are with US FDA, and 133 in Europe including with the EDQM and 102 in other countries. This is one of the highest filings.
NOT A BUY RECOMMENDATION
⚕️ *CUPID LIMITED: BUY TP 450*⚕️
*Rationale for Recommendation*
🎯 Low Equity Base & DEBT FREE.
🎯 Liquid Cash of ₹72 crores incl. ₹67.26 crores in Funds (as on Dec 4) & ₹4.51 crores of Fixed Deposits. Equivalent to ₹54 per share. Effective stock price is ₹197.
🎯 More than 20 years’ experience. In-house R&D Center. Contract manufacturing (OEM).
🎯 First company in the World to have been prequalified by WHO-UNFPA for supply of both Male & Female condoms. Exported condoms to 80+ countries.
🎯 Cupid’s manufacturing facility is designed to facilitate world-class manufacturing of quality products with Hitech German Technology Dipping Line as per GMP guidelines.
🎯 *Cupid’s confirmed order book stands at approx. ₹120 crores as on Oct 1, 2020.*
🎯 Cupid’s board has considered and approved the Service Provider and License Agreement between Cupid Limited and Invex Health Private Limited for *manufacturing of Medical Devices including various testing kits/diagnosing kits by Cupid Limited.*
⭕ *Cheapest Medical Devices stock in peer group PE is 45+ whereas Cupid is trading at 8.4x (FY20), 7.63 (FY21E) and 6.32x (FY22E).*
⭕ *Fairly reliable estimate/news/rumour/HoS that promoter may be selling out and a very efficient 24 carat Industrial Group may become Cupid Promoter. If this surprise news comes, stock will be rerated with much higher valuations and possible that stock price is ₹750 in 2 years as this potential white knight has massive financial muscle and marketing reach. Even if this event is delayed or don’t happen, Cupid Fair Value and Target Price is ₹450 in 15 months.*
_*“During 2019-20, Cupid commenced export of female condoms to Brazil and also exported male condoms to Tanzania and South Africa. The order from Brazil is by far the largest single order Cupid has received in its 27 years history. Our continued focus on penetrating new geographies enabled us to win exports orders from 8 new countries through UNFPA. Till date, the Company has sold its products to over 80 countries worldwide.*_
_*We are currently evaluating the possibility of setting up a joint venture facility in South Africa to initially produce female condoms and eventually male condoms as well. We have discussed our technical and financial proposal with the Department of Treasury and Department of Health in South Africa. We immense potential in setting up a manufacturing facility in the region as the South African government wants to promote their local production.”*_ _~ Omprakash Garg, CMD_
*Products & Capacity*
Cupid’s manufacturing facility is located at Sinnar near Nashik, about 200 km East of Mumbai.
♀️ *Male condoms*, _480 million pieces per annum._
♀️ *Female condoms*, _52 million pieces per annum._
♀️ *Water Based Lubricant Jelly*, _210 million sachets per annum._
♀️ *Clean & Safe Hand Sanitizer.*
♀️ *Clean & Safe Hair Remover.*
Great Eagle Capital
BUY CUPID 196 STOP LOSS 189 TARGET 272-283. Great Risk Reward UPCOMING DAY
5. #CUPID - a leading manufacturer & supplier of quality Male & Female Condoms was incorporated as a Public Limited Company in 1993 The companies modern facility has a current capacity of over 500 million pieces per year for ......read more
Dated 01-10-2021, LTP 232.45, given an up side Breakout from Downward Channel Pattern on daily chart with good Volume supprt. Most of the important technical indicators like MAcD, RSI, Stochastic etc turned bullish. Its a Buy candidate now ...
Lupin: The pharma company launched an authorised generic version of Brovana (arformoterol tartrate) Inhalation Solution 15 mcg/2 mL, unit-dose vials, of Sunovion Pharmaceuticals Inc, in the United States. The drug is used for the maintenance treatment of bronchocon......read more